Propanc Biopharma PPCB
NASDAQ PPCB
$0.32 0.00 (-1.12%)
As of: Oct 21, 2026 · 3:03 PM EDT

Propanc Biopharma (PPCB) Receivables - Other (2013 - 2016)

Updated

Propanc Biopharma (PPCB) posted Receivables - Other of $2,300 for fiscal Q1 2017 (quarter ended Sep 30, 2016), up 3.6% from the prior quarter.

Analysis

Propanc Biopharma (PPCB) Receivables - Other (2013 - 2016) Analysis & Trends

At the end of FY2016 (ended Jun 30, 2016), Propanc Biopharma's Receivables - Other came in at $2,220.

  • In prior fiscal years, Propanc Biopharma's Receivables - Other was -$130,689 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.68 Bn 1,105.26 Bn 19.71 Bn
2 Johnson & Johnson 617.43 Bn 535.95 Bn 17.26 Bn
3 AbbVie 501.53 Bn 474.64 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.54 Bn 261.53 Bn 11.24 Bn
6 Astrazeneca 260.75 Bn 234.43 Bn 12.86 Bn
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn
8 Gilead Sciences 191.10 Bn 165.30 Bn 6.22 Bn
9 Pfizer 169.66 Bn 116.31 Bn 10.94 Bn
10 Propanc Biopharma 356,665.25 -1.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 2,300.00
Jun 30, 2016 2,220.00
Dec 31, 2013 -116,552.00
Jun 30, 2013 -130,689.00
API Access

Propanc Biopharma Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PPCB&period=max&api_key=YOUR_API_KEY